Robert W. Yeh, MD MSc MBA
January 16th, 2014
Are All Carotid Stenting Systems Equal?
Jay Giri, MD, MPH and Robert W. Yeh, MD MSc MBA
Jay Giri and Robert W. Yeh discuss their research group’s analysis of patient-registry data on embolic protection devices that are commonly used in carotid artery stenting.
August 2nd, 2012
DES in Patients at Low Risk for TVR: Is the Benefit Worth the Cost? (Part III)
John Spertus, MD, MPH, Robert W. Yeh, MD MSc MBA, Richard A. Lange, MD, MBA and L. David Hillis, MD
In a recent article in Archives of Internal Medicine, researchers performed an analysis of current use of drug-eluting stents (DES) in patients at various levels of risk for target-vessel revascularization (TVR), and estimated the cost and clinical outcomes of using BMS rather than DES in patients at low risk (see News). To gauge reaction to […]
NEJM Journal Watch — Recent Cardiology Articles- Strategies and Criteria for the Diagnosis and Management of Myocarditis
- Sex-Based Disparity in CABG Outcomes: Are We Moving Toward Parity?
- Can Genetic and Social Risk Scores Improve Cardiac Risk Prediction?
- Extensive Ablation vs. Pulmonary Vein Isolation in Persistent Atrial Fibrillation
- Can a Novel Stent Design Improve Long-Term Outcomes of Percutaneous Coronary Intervention?